GlassScriptPhysician profile
Matthew Emanuel Citron
NPI 1942258306
$2,449.94
in general payments reported to CMS, 2019-2025
12 companies · $515 in 2025
The $515 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $271 · 2021: $72.09 · 2022: $482 · 2023: $281 · 2024: $604 · 2025: $515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,400.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $968.17 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument |
| Alcon Vision LLC | $464.07 | 2019-2023 | Hydrus Microstent |
| Abbvie INC. | $421.48 | 2022-2025 | |
| New World Medical,INC. | $320.65 | 2020-2024 | Ahmed Glaucoma Valve, Clearpath, Kahook Dual Blade |
| Thea Pharma INC. | $117.68 | 2022-2025 | Iyuzeh |
| Aerie Pharmaceuticals, INC. | $52.34 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $23.84 | 2019 | |
| Akorn, INC. | $19.35 | 2019 | |
| Kala Pharmaceuticals, INC. | $17.99 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.23 | 2021 | |
| Beaver-Visitec International, INC. | $15.39 | 2021 | |
| Allergan, INC. | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Citron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.